SCHEMBL4834867

SCHEMBL4834867

COc1cc(OC)cc(C(=O)Nc2ccc(C(=O)C=C3NC(C)(C)Cc4ccc(OC)cc43)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.43
MEN1 O00255 6/20 0.43
CASP3 P42574 2/20 0.43
SENP8 Q96LD8 2/20 0.43
SENP7 Q9BQF6 2/20 0.43
SENP6 Q9GZR1 2/20 0.43
MAPT P10636 4/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 4/20 0.42
TP53 P04637 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4834858 1.00 KMT2A (0.43) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL4839109 0.94 RAB9A (0.49) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4839102 0.94 RAB9A (0.49) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4837792 0.93 KMT2A (0.51) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4837807 0.93 KMT2A (0.51) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4838356 0.92 TAS1R3 (0.41) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4838367 0.92 TAS1R3 (0.41) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4835216 0.92 NPC1 (0.51) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4835233 0.92 NPC1 (0.51) KMT2AMEN1MAPTNPC1TP53
SCHEMBL4844437 0.92 KMT2A (0.47) KMT2AMEN1MAPTNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 KMT2A 4642/4885MEN1 1230/4885CASP3 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.